Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CENTENE CORPCNC · Entity 3133 | Director | June 10, 2026 | June 11, 2026 |
| FIRST HORIZON CORPFHN · Entity 3480 | Director | May 03, 2022 | May 05, 2022 |
| LifeStance Health Group, Inc.LFST · Entity 3936 | Director | August 11, 2026 | August 13, 2026 |
| Orion Acquisition Corp.OHPA · Entity 126732 | Director | March 01, 2021 | March 03, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CENTENE CORP
Report date June 10, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 197,085.924 |
Reported balance
After 2026-06-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-10 · Sale · Disposed 80,000 · Balance 197,085.924 F1: The weighted average price for this transaction is reported within the form. Shares were sold at prices ranging from $64.55 to $64.61. Full information regarding the number of shares at each price is available upon request. F2: Ownership includes 3,992 shares of restricted stock units subject to vesting requirements. |
| Common StockSEC Table I · non-derivative | IndirectBy Burdick Family LLC | 86,498 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 86,498 F3: Owned by the Burdick Family LLC, of which Mr. Burdick is a chief manager. Mr. Burdick disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: The weighted average price for this transaction is reported within the form. Shares were sold at prices ranging from $64.55 to $64.61. Full information regarding the number of shares at each price is available upon request.
F2: Ownership includes 3,992 shares of restricted stock units subject to vesting requirements.
F3: Owned by the Burdick Family LLC, of which Mr. Burdick is a chief manager. Mr. Burdick disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
FIRST HORIZON CORP
Report date May 03, 2022 · Filed May 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,253 |
Reported balance
After 2022-05-03 transaction · row 1
1 source rowRow 1 · 2022-05-03 · Grant · Acquired 6,385 · Balance 44,253 F1: Grant of restricted stock units which will vest April 22, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units which will vest April 22, 2023.
LifeStance Health Group, Inc.
Report date August 11, 2026 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,970,810 |
Reported balance
After 2026-08-11 transaction · row 1
1 source rowRow 1 · 2026-08-11 · Sale · Disposed 500,000 · Balance 2,970,810 F1: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $11.50 to $11.665 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| Common StockSEC Table I · non-derivative | IndirectBy Burdick Family LLC | 46,511 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 46,511 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $11.50 to $11.665 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Orion Acquisition Corp.
Report date March 01, 2021 · Filed March 03, 2021
This filing explicitly reported no securities owned.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
WELLCARE HEALTH PLANS, INC.
Report date January 23, 2020 · Filed January 27, 2020
Section 16 reporting ended · disclosed 2020-01-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-01-23 transaction · row 1
1 source rowRow 1 · 2020-01-23 · Disposition to issuer · Acquired 247,644 · Balance 0 F1: Reflects disposition in connection with the Agreement and Plan of Merger (the "Merger Agreement") dated March 26, 2019, by and among WellCare Health Plans, Inc. ("WellCare"), Centene Corporation ("Centene"), Wellington Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Centene ("Merger Sub I"), and other parties thereto, pursuant to which Merger Sub I merged with and into WellCare on January 23, 2020 (the "Effective Time"). Upon the Effective Time, each share of WCG common stock held by the Reporting Person were converted into the right to receive (i) $120.000 in cash and (ii) 3.38 validly issued, fully paid and non assessable shares of Centene's common stock, par value $0.001 per share. Upon the Effective Time, restricted stock units ("RSUs") representing 44,834 shares of WCG common stock held by the Reporting Person were converted into RSUs relating to Centene common stock in accordance with the exchange ratio set forth in the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition in connection with the Agreement and Plan of Merger (the "Merger Agreement") dated March 26, 2019, by and among WellCare Health Plans, Inc. ("WellCare"), Centene Corporation ("Centene"), Wellington Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Centene ("Merger Sub I"), and other parties thereto, pursuant to which Merger Sub I merged with and into WellCare on January 23, 2020 (the "Effective Time"). Upon the Effective Time, each share of WCG common stock held by the Reporting Person were converted into the right to receive (i) $120.000 in cash and (ii) 3.38 validly issued, fully paid and non assessable shares of Centene's common stock, par value $0.001 per share. Upon the Effective Time, restricted stock units ("RSUs") representing 44,834 shares of WCG common stock held by the Reporting Person were converted into RSUs relating to Centene common stock in accordance with the exchange ratio set forth in the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2026 Filed Aug 13, 2026 21:02 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 500,000 | $11.51 | $5,755,000.00 |
DisclosureSEC source: 0001193125-26-349559 · ownership.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,970,810 F1 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $11.50 to $11.665 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 06, 2026 Filed Jul 14, 2026 22:12 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 45,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-303501 · ownership.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,470,810 F1 · shares: Includes 45,495 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 21:22 UTC | CENTENE CORP CNC · Entity 3133 | SaleCommon Stock | 80,000 | $64.55 | $5,164,000.00 |
DisclosureSEC source: 0001071739-26-000127 · wk-form4_1781212935.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,085.924 F1 · price: The weighted average price for this transaction is reported within the form. Shares were sold at prices ranging from $64.55 to $64.61. Full information regarding the number of shares at each price is available upon request. F2 · balance_after: Ownership includes 3,992 shares of restricted stock units subject to vesting requirements. Read SEC document |
| May 12, 2026 Filed May 13, 2026 21:17 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 3,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-26-000109 · wk-form4_1778707044.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,085.924 F1 · shares: This award includes 3,992 shares of restricted stock units which will vest in full on the earlier of May 12, 2027, or the date of the Registrant's next annual meeting of stockholders. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 23:07 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 278,192 | $6.91 | $1,922,306.72 |
DisclosureSEC source: 0001193125-26-102657 · ownership.xml · nonDerivative · entry 5 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,425,315 F5 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 23:07 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 706,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-102657 · ownership.xml · nonDerivative · entry 4 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,703,507 F4 · shares: Represents PSUs previously granted to the Reporting Person on February 27, 2025, which vested on March 9, 2026. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 23:07 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 13,201 | $6.91 | $91,218.91 |
DisclosureSEC source: 0001193125-26-102657 · ownership.xml · nonDerivative · entry 3 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,996,547 F3 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 23:07 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 33,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-102657 · ownership.xml · nonDerivative · entry 2 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,009,748 F2 · shares: Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 23:07 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 35,816 | $6.91 | $247,488.56 |
DisclosureSEC source: 0001193125-26-102657 · ownership.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,976,204 F1 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 00:11 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 424,551 | $7.11 | $3,018,557.61 |
DisclosureSEC source: 0001193125-26-099063 · ownership.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,012,020 F1 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 6, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:55 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-26-000004 · wk-form4_1767650119.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,093.924 F1 · balance_after: Ownership includes 3,579 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 22:06 UTC | CENTENE CORP CNC · Entity 3133 | SaleCommon Stock | 32,796 | $39.00 | $1,279,044.00 |
DisclosureSEC source: 0001071739-25-000190 · wk-form4_1764972397.xml · nonDerivative · entry 2 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,364.924 F2 · balance_after: Ownership includes 3,579 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 22:06 UTC | CENTENE CORP CNC · Entity 3133 | SaleCommon Stock | 33,211 | $39.04 | $1,296,557.44 |
DisclosureSEC source: 0001071739-25-000190 · wk-form4_1764972397.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,160.924 F1 · price: The weighted average price for this transaction is reported within the form. Shares were sold at prices ranging from $39.00 to $39.11. Full information regarding the number of shares at each price is available upon request. F2 · balance_after: Ownership includes 3,579 shares of restricted stock units subject to vesting requirements. Read SEC document |
| September 30, 2025 Filed Oct 1, 2025 21:46 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 852 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-25-000174 · wk-form4_1759355200.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,371.924 F1 · balance_after: Ownership includes 3,579 shares of restricted stock units subject to vesting requirements. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 20:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | PurchaseCommon Stock | 18,660 | $4.54 | $84,716.40 |
DisclosureSEC source: 0000950170-25-107382 · ownership.xml · nonDerivative · entry 4 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,436,571 Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 20:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | PurchaseCommon Stock | 1,340 | $4.35 | $5,829.00 |
DisclosureSEC source: 0000950170-25-107382 · ownership.xml · nonDerivative · entry 3 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,417,991 Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | PurchaseCommon Stock | 46,511 | $4.30 | $199,997.30 |
DisclosureSEC source: 0000950170-25-107382 · ownership.xml · nonDerivative · entry 5 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Burdick Family LLC Disclosed balance after: 46,511 Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | PurchaseCommon Stock | 1,800 | $4.31 | $7,758.00 |
DisclosureSEC source: 0000950170-25-107382 · ownership.xml · nonDerivative · entry 2 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,416,571 Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | PurchaseCommon Stock | 45,870 | $4.36 | $199,993.20 |
DisclosureSEC source: 0000950170-25-107382 · ownership.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,414,771 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:59 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 556 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-25-000144 · wk-form4_1751489931.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,052.924 F1 · balance_after: Ownership includes 3,579 shares of restricted stock units subject to vesting requirements. Read SEC document |
| May 13, 2025 Filed May 14, 2025 21:22 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 3,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-25-000105 · wk-form4_1747257734.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 366,496.924 F1 · shares: This award includes 3,579 shares of restricted stock units which will vest in full on the earlier of May 13, 2026, or the date of the Registrant's next annual meeting of stockholders. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:07 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-25-000074 · wk-form4_1743628038.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 362,917.924 F1 · balance_after: Ownership includes 2,916 shares of restricted stock units subject to vesting requirements. Read SEC document |
| March 10, 2025 Filed May 20, 2025 00:50 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 35,817 | $7.11 | $254,658.87 |
DisclosureSEC source: 0000950170-25-074782 · ownership.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,368,901 F1 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 10, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 00:51 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 166,762 | $7.59 | $1,265,723.58 |
DisclosureSEC source: 0000950170-25-036736 · ownership.xml · nonDerivative · entry 6 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,404,718 F6 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 00:51 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 423,790 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036736 · ownership.xml · nonDerivative · entry 5 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,571,480 F5 · shares: Represents PSUs previously granted to the Reporting Person on February 28, 2024, which vested on March 7, 2025. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 00:51 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 111,430 | $7.59 | $845,753.70 |
DisclosureSEC source: 0000950170-25-036736 · ownership.xml · nonDerivative · entry 4 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,147,690 F4 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 00:51 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 283,172 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036736 · ownership.xml · nonDerivative · entry 3 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,259,120 F3 · shares: Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 8, 2024, which vested on March 7, 2025. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:51 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | Tax withholdingCommon Stock | 53,602 | $7.88 | $422,383.76 |
DisclosureSEC source: 0000950170-25-036736 · ownership.xml · nonDerivative · entry 2 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,975,948 F2 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:51 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 95,178 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036736 · ownership.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,029,550 F1 · shares: Includes 95,178 restricted stock units ("RSUs") granted on March 6, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:52 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 497 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-25-000006 · wk-form4_1735941156.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 362,417.924 F1 · balance_after: Ownership includes 2,916 shares of restricted stock units subject to vesting requirements. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 21:11 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 402 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-24-000181 · wk-form4_1727903474.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 361,920.924 F1 · balance_after: Ownership includes 2,916 shares of restricted stock units subject to vesting requirements. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 21:35 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 452 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-24-000143 · wk-form4_1719956110.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 361,518.924 F1 · balance_after: Ownership includes 2,916 shares of restricted stock units subject to vesting requirements. Read SEC document |
| May 14, 2024 Filed May 16, 2024 22:13 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 2,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-24-000117 · wk-form4_1715897588.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 361,066.924 F1 · shares: This award includes 2,916 shares of restricted stock units which will vest in full on the earlier of May 14, 2025, and the date of the Registrant's next annual meeting of stockholders. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 23:36 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 388.551 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-24-000086 · wk-form4_1712100991.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 358,150.924 F1 · balance_after: Ownership includes 2,947 shares of restricted stock subject to vesting requirements. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 214,605 | $6.28 | $1,347,719.40 |
DisclosureSEC source: 0000950170-24-033540 · ownership.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,934,372 F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 01:48 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 423,790 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030455 · ownership.xml · nonDerivative · entry 2 Burdick Kenneth A · CIK 0001498992 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,148,977 F2 · shares: Represents performance-based restricted stock units previously granted to the Reporting Person, which vested on March 8, 2024. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 01:48 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 364,077 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030455 · ownership.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,725,187 F1 · shares: Includes 364,077 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 06, 2024 Filed Feb 9, 2024 00:37 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 33,066 | $74.07 | $2,449,198.62 |
DisclosureSEC source: 0001071739-24-000027 · wk-form4_1707439050.xml · nonDerivative · entry 2 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 357,762.373 F2 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F3 · balance_after: Ownership includes 2,947 shares of restricted stock subject to vesting requirements. Read SEC document |
| February 06, 2024 Filed Feb 9, 2024 00:37 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 18,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-24-000027 · wk-form4_1707439050.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,828.373 F1 · shares: Represents the additional number of shares earned from a previously reported performance stock unit grant from January 2021 with a three-year performance period. Refer to Form 3 filed on January 14, 2022. 70,316 shares were initially reported at target level performance. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 23:29 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 485.168 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-24-000009 · wk-form4_1704324578.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372,265.373 F1 · balance_after: Ownership includes 73,263 shares of restricted stock subject to vesting requirements. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 22:51 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 526.078 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000198 · wk-form4_1696373472.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,780.205 F1 · balance_after: Ownership includes 73,263 shares of restricted stock subject to vesting requirements. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 23:38 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 524.816 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000171 · wk-form4_1688600294.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,254.127 F1 · balance_after: Ownership includes 73,263 shares of restricted stock units subject to vesting requirements. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:19 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 2,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000136 · wf-form4_168392996328015.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 370,729.311 F1 · balance_after: Ownership includes 2,947 shares of restricted stock which will vest in full on the earlier of May 10, 2024 and the date of the Registrant's next annual meeting of stockholders. In addition, ownership includes 70,316 shares of restricted stock units subject to vesting requirements. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 01:16 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 493.027 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000102 · wf-form4_168065736217832.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,782.311 F1 · balance_after: Ownership includes 72,639 shares of restricted stock units subject to vesting requirements. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 22:18 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 544,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007556 · doc4.xml · nonDerivative · entry 2 Burdick Kenneth A · CIK 0001498992 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,361,110 F2 · shares: Includes 544,871 RSUs. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 22:18 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 1,816,239 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007556 · doc4.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,816,239 F1 · shares: Includes 1,816,239 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 02:20 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 29,922 | $71.01 | $2,124,761.22 |
DisclosureSEC source: 0001071739-23-000034 · wf-form4_167599560206071.xml · nonDerivative · entry 2 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,289.284 F2 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F3 · balance_after: Ownership includes 72,639 shares of restricted stock units subject to vesting requirements. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 02:20 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 1,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000034 · wf-form4_167599560206071.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,211.284 F1 · shares: Represents the additional number of shares earned from a previously reported performance stock unit grant from March 2020 with a three-year performance period. Refer to Form 4 filed on March 4, 2020. 79,215 shares were reported based on achievement of target level of performance. Read SEC document |
| December 31, 2022 Filed Jan 5, 2023 00:08 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 428.501 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000014 · wf-form4_167287726032655.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,310.284 F1 · balance_after: Ownership includes 151,854 shares of restricted stock units subject to vesting requirements. Read SEC document |
| September 30, 2022 Filed Oct 5, 2022 01:10 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 366.544 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-22-000348 · wf-form4_166493213112361.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,881.783 F1 · balance_after: Ownership includes 151,854 shares of restricted stock units subject to vesting requirements. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.